TIKVA ALLOCELL PTE. LTD.
Country of registration | Singapore |
Registration number | 202327698Z |
Local SIC | |
Incorporation date | 13 Jul 2023 |
Company age | 2 years 10 months |
Official entity type | Exempt Private Limited Company |
No. of officers | 4 |
Contact
61 BIOPOLIS DRIVE, #03-09, PROTEOS, Singapore 138673
This is the legal entity page of TIKVA ALLOCELL PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- TIKVA ALLOCELL PTE LTDView MoreSingaporeTikva Allocell is a cell therapy company focused on a Second Generation Allogeneic EBV-Specific T cell (ALLO EBVST) platform to target difficult-to-treat cancers. At Tikva Allocell, our mission is to develop safe, effective, readily available and affordable “off-the-shelf” T cell therapies by leveraging excellent safety profile of ALLO EBVST and proprietary technologies that enhance the T cell's performance to treat cancer.
Revenue | < 1m |
Share Capital - Ordinary shares | SGD 1 |
Frequently Asked Questions (FAQ)
- What is the address of TIKVA ALLOCELL PTE. LTD.?
- Where is TIKVA ALLOCELL PTE. LTD.'s headquarter?
- What is TIKVA ALLOCELL PTE. LTD.'s contact number?
- What TIKVA ALLOCELL PTE. LTD.'s spending power?
- Does TIKVA ALLOCELL PTE. LTD. have a presence in the domain it operates in?

